Researchers map druggable genomic targets in evolving malaria parasite

Researchers have used whole genome analyses and chemogenetics to identify new drug targets and resistance genes in 262 parasite cell lines of Plasmodium falciparum -- protozoan pathogens that cause malaria -- that are resistant to 37 diverse antimalarial compounds.